WallStreetZenWallStreetZen

NASDAQ: XOMA
Xoma Corp Stock Forecast, Predictions & Price Target

Analyst price target for XOMA

Based on 2 analysts offering 12 month price targets for Xoma Corp.
Min Forecast
$56.00+168.59%
Avg Forecast
$62.50+199.76%
Max Forecast
$69.00+230.94%

Should I buy or sell XOMA stock?

Based on 3 analysts offering ratings for Xoma Corp.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
0 analysts 0%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their XOMA stock forecasts and price targets.

Forecast return on equity

Is XOMA forecast to generate an efficient return?
Company
N/A
Industry
-0.06%
Market
12.46%

Forecast return on assets

Is XOMA forecast to generate an efficient return on assets?
Company
N/A
Industry
0.08%

XOMA earnings per share forecast

What is XOMA's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$0.28-131.46%
Avg 2 year Forecast
$1.17+31.46%
Avg 3 year Forecast
$2.57+188.76%
XOMA's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

XOMA revenue forecast

What is XOMA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$26.7M-34.05%
Avg 2 year Forecast
$37.8M-6.63%
Avg 3 year Forecast
$64.1M+58.33%
XOMA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XOMA earnings growth forecast

How is XOMA forecast to perform vs Biotechnology companies and vs the US market?
Company
42.57%
Industry
6.97%
Market
24.23%
XOMA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
XOMA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
XOMA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

XOMA revenue growth forecast

How is XOMA forecast to perform vs Biotechnology companies and vs the US market?
Company
15%
Industry
40.02%
Market
9.31%
XOMA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XOMA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XOMA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
XOMA$20.85$62.50+199.76%Strong Buy
LCTX$1.40$4.50+221.43%Strong Buy
VERA$8.74$16.75+91.65%Buy
ORIC$6.13$9.00+46.82%Buy
ANTX$12.57$24.00+90.93%Buy

Xoma Stock Forecast FAQ

Is Xoma Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: XOMA) stock is to Strong Buy XOMA stock.

Out of 3 analysts, 2 (66.67%) are recommending XOMA as a Strong Buy, 0 (0%) are recommending XOMA as a Buy, 1 (33.33%) are recommending XOMA as a Hold, 0 (0%) are recommending XOMA as a Sell, and 0 (0%) are recommending XOMA as a Strong Sell.

If you're new to stock investing, here's how to buy Xoma stock.

What is XOMA's earnings growth forecast for 2023-2025?

(NASDAQ: XOMA) Xoma's forecast annual earnings growth rate of 42.57% is forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 6.97%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 24.23%.

Xoma's earnings in 2023 is $9,793,000.On average, 3 Wall Street analysts forecast XOMA's earnings for 2023 to be -$3,206,230, with the lowest XOMA earnings forecast at -$10,992,790, and the highest XOMA earnings forecast at $6,526,969. On average, 1 Wall Street analyst forecast XOMA's earnings for 2024 to be $13,397,463, with the lowest XOMA earnings forecast at $13,397,463, and the highest XOMA earnings forecast at $13,397,463.

In 2025, XOMA is forecast to generate $29,428,615 in earnings, with the lowest earnings forecast at $29,428,615 and the highest earnings forecast at $29,428,615.

What is XOMA's revenue growth forecast for 2023-2025?

(NASDAQ: XOMA) Xoma's forecast annual revenue growth rate of 15% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 40.02%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.31%.

Xoma's revenue in 2023 is $40,486,000.On average, 1 Wall Street analysts forecast XOMA's revenue for 2023 to be $305,736,974, with the lowest XOMA revenue forecast at $305,736,974, and the highest XOMA revenue forecast at $305,736,974. On average, 1 Wall Street analysts forecast XOMA's revenue for 2024 to be $432,841,109, with the lowest XOMA revenue forecast at $432,841,109, and the highest XOMA revenue forecast at $432,841,109.

In 2025, XOMA is forecast to generate $733,997,754 in revenue, with the lowest revenue forecast at $733,997,754 and the highest revenue forecast at $733,997,754.

What is XOMA's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: XOMA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.08%.

What is XOMA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year XOMA price target, the average XOMA price target is $62.50, with the highest XOMA stock price forecast at $69.00 and the lowest XOMA stock price forecast at $56.00.

On average, Wall Street analysts predict that Xoma's share price could reach $62.50 by Aug 4, 2023. The average Xoma stock price prediction forecasts a potential upside of 199.76% from the current XOMA share price of $20.85.

What is XOMA's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: XOMA) Xoma's current Earnings Per Share (EPS) is $0.89. On average, analysts forecast that XOMA's EPS will be -$0.28 for 2023, with the lowest EPS forecast at -$0.96, and the highest EPS forecast at $0.57. On average, analysts forecast that XOMA's EPS will be $1.17 for 2024, with the lowest EPS forecast at $1.17, and the highest EPS forecast at $1.17. In 2025, XOMA's EPS is forecast to hit $2.57 (min: $2.57, max: $2.57).

What is XOMA's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: XOMA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.